Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet
Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read MoreSome health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read MoreThe FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are
Read MoreWhile weight loss drugmakers are catching a bid with investors, experts are less certain that ETFs linked to the category
Read MoreThese are the stocks posting the largest moves in early trading. Source link
Read MoreAmazon Pharmacy second online pharmacy to partner with Eli Lilly's site, and could provide faster deliveries for certain patients. Source
Read MoreWhen stocks are in steep uptrends, it can difficult be difficult to determine when a meaningful corrective move is going
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThe FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer's treatment's
Read MoreNovo Nordisk shares climbed 5% on Thursday morning after the Danish pharmaceutical giant reported positive early trial data for a
Read More